(Q44368180)

2 December 2017

Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica (English)

1 reference

2 December 2017

1 reference

1 reference

Parietaria judaica

1 reference

García-Sellés J

1

1 reference

2 December 2017

Pascual A

2

1 reference

2 December 2017

Funes E

3

1 reference

2 December 2017

Pagán JA

4

1 reference

2 December 2017

López JD

5

1 reference

2 December 2017

Negro JM

6

1 reference

2 December 2017

Hernández J

7

1 reference

2 December 2017

1 March 2003

1 reference

Allergologia et Immunopathologia

2 December 2017

1 reference

2 December 2017

31

1 reference

2 December 2017

2

1 reference

2 December 2017

63-69

1 reference

Pollen-related allergy in Europe

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Safety and immunogenicity of immunotherapy with accelerated dosage schedules of polymerized grass and ragweed in patients with dual inhalant sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

A double-blind placebo-controlled trial of polymerized whole grass administered in an accelerated dosage schedule for immunotherapy of grass pollinosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Modified forms of allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Safety considerations in assessing the role of immunotherapy in allergic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Allergenic pollen pollinosis in Madrid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

The use of glutaraldehyde as a coupling agent for ribonuclease and bovine serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Comparison of skin-prick test assay and reverse enzyme immunoassay competition (REINA-C) for biological activity of allergens.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Evaluation of the potency of allergenic extracts by inhibition of IgG-antibody binding

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Methodological aspects of nasal allergen challenges based on a three-year tree pollen immunotherapy study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2803%2979170-8

7 January 2021

10.1016/S0301-0546(03)79170-8

Identifiers

DOI

1 reference

2 December 2017

1 reference